Table 2 Clinical comparison between non-metabolic and MetS subjects with normal and elevated APRI score in the study population.
Clinical variable | MetS NO | MetS YES | p-value | ||
|---|---|---|---|---|---|
APRI < 0.5 | APRI > 0.5 | APRI < 0.5 | APRI > 0.5 | ||
n (M:F) | 587 (283:304) | 98 (53:45) | 406 (216:200) | 134 (71:63) | – |
Weight (kg) | 73.43 ± 0.70 | 78.93 ± 2.44 | 84.04 ± 0.81a | 87.21 ± 2.01 | < 0.05 |
Waist circumference (cm) | 91.99 ± 0.61 | 95.24 ± 1.68 | 106.66 ± 0.61a,b | 106.54 ± 1.32a | < 0.01 |
BMI (kg/m2) | 25.62 ± 0.39 | 26.95 ± 1.23 | 30.62 ± 0.31 | 30.59 ± 1.43 | NS |
Sistolic blood pressure (mmHg) | 120.94 ± 0.74 | 124.71 ± 2.09 | 134.61 ± 0.90a | 134.41 ± 1.51a | < 0.05 |
Diastolic blood pressure (mmHg) | 76.15 ± 0.32 | 76.13 ± 1.10 | 80.77 ± 0.31 | 81.55 ± 1.04 | NS |
Platelet count (106/μL) | 245.11 ± 2.76 | 172.74 ± 4.99a,c | 243.31 ± 2.31 | 179.94 ± 4.93a,c | < 0.05 |
Hemoglobin (g/dl) | 13.91 ± 0.12 | 14.10 ± 0.31 | 13.81 ± 1.31 | 14.10 ± 0.13 | NS |
WBC (103/µl) | 6.03 ± 0.08 | 5.60 ± 0.28 | 7.04 ± 1.83 | 6.30 ± 0.16 | NS |
Monocytes (%) | 6.24 ± 0.07 | 6.81 ± 0.34 | 6.21 ± 0.04 | 6.78 ± 0.19 | NS |
Lymphocytes (%) | 33.01 ± 0.38 | 32.89 ± 1 | 30.37 ± 0.38 | 32.98 ± 0.94 | NS |
Neutrophils (%) | 57.51 ± 0.31 | 56.54 ± 1.21 | 59.42 ± 0.29 | 57.07 ± 0.94 | NS |
Basophils (%) | 0.53 ± 0.03 | 0.6 ± 0.04 | 0.53 ± 0.02 | 0.56 ± 0.03 | NS |
Eosinophils (%) | 2.73 ± 0.11 | 2.82 ± 0.32 | 2.71 ± 0.99 | 2.78 ± 0.21 | NS |
Glucose (mg/dl) | 88.27 ± 0.81 | 92.30 ± 2.89 | 116 ± 2.82a,b | 120.61 ± 3.94a,b | < 0.05 |
HbA1c (mmol/mol) | 37.47 ± 0.30 | 37.89 ± 1.51 | 47.82 ± 0.94a,b | 46.83 ± 1.41a,b | < 0.05 |
Total cholesterol (mg/dl) | 189.04 ± 1.09 | 174.38 ± 4.31 | 175.12 ± 1.40 | 181.15 ± 3.99 | NS |
HDL-c (mg/dl) | 60.65 ± 0.51 | 54.69 ± 2.31 | 47.01 ± 0.71a,b | 44.44 ± 1.32a,b | < 0.01 |
LDL-c (mg/dl) | 110.42 ± 1.21 | 99.5 ± 4.40 | 99.31 ± 1.14 | 99.32 ± 3.42 | NS |
TG (mg/dl) | 91.54 ± 1.32 | 95.64 ± 3.84 | 158.13 ± 4.31a,b | 165 ± 7.99a,b | < 0.05 |
AST (U/I) | 20.06 ± 0.21 | 34.73 ± 1.03a | 20.54 ± 0.31 | 41.88 ± 1.52a,c | < 0.01 |
ALT (U/I) | 26.35 ± 0.37 | 43.86 ± 2.96a,c | 29.79 ± 1.02 | 58.34 ± 3.25a,c | < 0.05 |
ALP (U/I) | 66.47 ± 1.42 | 75.19 ± 2.98 | 72.12 ± 1.42 | 73.36 ± 2.52 | NS |
GGT (U/I) | 27.11 ± 0.88 | 47 ± 4.93a | 37.32 ± 1.32 | 62.17 ± 5.31a,c | < 0.01 |
Ferritin (ng/ml) | 96.32 ± 3.98 | 159.29 ± 13.99a,c | 114.32 ± 9.48a | 180.73 ± 18.33a,c | < 0.05 |
Iron (µg/dl) | 84.21 ± 2.50 | 93.98 ± 7.12 | 86.32 ± 3.29 | 75.53 ± 4.23b | NS |
Creatinine (mg/dl) | 0.80 ± 1.49 | 0.86 ± 0.02 | 0.91 ± 1.99 | 0.87 ± 2.01 | NS |
Uric acid (mg/dl) | 53.83 ± 0.18 | 57.99 ± 0.40 | 58.02 ± 0.31 | 60.33 ± 0.91a | NS |
Total protein (g/dl) | 7.24 ± 1.40 | 7.22 ± 4.81 | 7.30 ± 4.32 | 7.41 ± 5.01 | NS |
Albumin (g/dl) | 4.63 ± 0.84 | 4.43 ± 2.85 | 5.13 ± 0.59 | 4.37 ± 0.15 | NS |
ESR (mm/h) | 14.02 ± 0.48 | 14.24 ± 1.73 | 21.32 ± 1.11a,b | 18.91 ± 1.94 | NS |
Hs-CRP (mg/l) | 3.68 ± 0.17 | 3.76 ± 0.32 | 4.93 ± 0.42 | 4.50 ± 0.36 | NS |
TSH (mUI/L) | 1.84 ± 0.10 | 2.02 ± 0.17 | 2.09 ± 0.63 | 1.96 ± 0.23 | NS |
FT3 (pg/ml) | 2.82 ± 1.83 | 2.82 ± 6.01 | 2.76 ± 2.96 | 2.80 ± 5.83 | NS |
FT4 (ng/dl) | 1.01 ± 1.12 | 0.99 ± 0.84 | 1.06 ± 1.45 | 1.07 ± 2.99 | NS |
Ab anti TG (UI/ml) | 42.73 ± 12.01 | 42.69 ± 27.31 | 96 ± 47.86 | 15.36 ± 2.44 | NS |
Ab anti TPO (UI/ml) | 441.71 ± 160.54 | 38.83 ± 13.93 | 259.96 ± 214.93 | 19.10 ± 2.86 | NS |
Cardiovascular risk (Framingham) | 9.93 ± 0.83 | 21.95 ± 1.54a | 24.51 ± 0.91a | 39.97 ± 2.01a,b,c | < 0.01 |
FIB-4 score | 1.13 ± 0.14 | 1.58 ± 0.16 | 1.04 ± 0.03 | 2.05 ± 0.21a,c | < 0.05 |
APRI score | 0.28 ± 0.06 | 0.67 ± 0.04a,c | 0.28 ± 0.02 | 0.84 ± 0.09a,c | < 0.01 |